X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
non-valvular atrial fibrillation (243) 243
index medicus (127) 127
warfarin (122) 122
humans (112) 112
stroke (94) 94
aged (85) 85
female (83) 83
male (81) 81
atrial fibrillation - drug therapy (64) 64
dabigatran (64) 64
atrial fibrillation (61) 61
middle aged (61) 61
cardiac & cardiovascular systems (60) 60
rivaroxaban (56) 56
stroke prevention (52) 52
anticoagulants (51) 51
anticoagulation (51) 51
anticoagulants - therapeutic use (47) 47
aged, 80 and over (46) 46
apixaban (46) 46
medicine, general & internal (41) 41
prevention (39) 39
atrial fibrillation - complications (38) 38
management (38) 38
risk (38) 38
stroke - prevention & control (38) 38
risk factors (36) 36
therapy (34) 34
cardiac arrhythmia (30) 30
direct oral anticoagulants (28) 28
prevalence (27) 27
administration, oral (26) 26
anticoagulants - administration & dosage (26) 26
retrospective studies (26) 26
safety (26) 26
hematology (25) 25
peripheral vascular disease (25) 25
oral anticoagulants (23) 23
oral anticoagulation (23) 23
treatment outcome (23) 23
warfarin - therapeutic use (23) 23
anticoagulants - adverse effects (22) 22
medicine & public health (22) 22
antithrombotic therapy (21) 21
fibrillation (21) 21
stroke - etiology (21) 21
thromboembolism (21) 21
analysis (20) 20
cardiology (20) 20
care and treatment (19) 19
hemorrhage - chemically induced (19) 19
atrial fibrillation - epidemiology (18) 18
mortality (18) 18
medicine, research & experimental (17) 17
adult (16) 16
atrial fibrillation - diagnosis (16) 16
cardiovascular diseases (16) 16
efficacy (16) 16
atrial fibrillation - blood (15) 15
cardiovascular (15) 15
comorbidity (15) 15
diseases of the circulatory system (15) 15
non‐valvular atrial fibrillation (15) 15
outcomes (15) 15
patients (15) 15
health care sciences & services (14) 14
metaanalysis (14) 14
association (13) 13
disease (13) 13
internal medicine (13) 13
international normalized ratio (13) 13
major bleeding (13) 13
medicine (13) 13
non valvular atrial fibrillation (13) 13
risk-factors (13) 13
rivaroxaban - therapeutic use (13) 13
clinical neurology (12) 12
cost-effectiveness (12) 12
dabigatran - therapeutic use (12) 12
drug therapy (12) 12
edoxaban (12) 12
guidelines (12) 12
ischemic stroke (12) 12
japanese patients (12) 12
population (12) 12
predicting stroke (12) 12
prospective studies (12) 12
research (12) 12
stroke - epidemiology (12) 12
hypertension (11) 11
ischemic-stroke (11) 11
medication adherence (11) 11
original (11) 11
persistence (11) 11
pyrazoles - therapeutic use (11) 11
pyridones - therapeutic use (11) 11
studies (11) 11
warfarin - administration & dosage (11) 11
warfarin - adverse effects (11) 11
adherence (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (229) 229
Spanish (22) 22
Japanese (17) 17
German (7) 7
Russian (6) 6
Portuguese (5) 5
Czech (3) 3
French (3) 3
Chinese (2) 2
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 11/2016, Volume 116, Issue 5, pp. 975 - 986
In addition to warfarin, there are four non-vitamin K antagonist oral anticoagulants (NOACs) available for stroke prevention in non valvular atrial... 
Rivaroxaban | Warfarin | Dabigatran | Non-valvular atrial fibrillation | Major bleeding | Apixaban | EFFICACY | SAFETY | rivaroxaban | apixaban | ASPIRIN | warfarin | STROKE | major bleeding | ORAL ANTICOAGULANTS | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
Journal Article
Circulation Journal, ISSN 1346-9843, 2018, Volume 83, Issue 1, pp. 67 - 74
Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective non-interventional study of stroke... 
GARFIELD-AF | Oral anticoagulation | Non-valvular atrial fibrillation | STROKE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | WARFARIN | REGISTRY
Journal Article
Circulation Journal, ISSN 1346-9843, 2018, Volume 82, Issue 10, pp. 2647 - 2654
Background: This study investigated changes in anticoagulant use, treatment, and functional outcomes in acute ischemic stroke (AIS) patients with non-valvular... 
Non-valvular atrial fibrillation | Reperfusion therapy | Oral anticoagulants | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | WARFARIN | INTENSITY | PREVALENCE | INTERNATIONAL NORMALIZED RATIO | JAPANESE PATIENTS
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2017, Volume 56, Issue 6, pp. 1072 - 1082
Summary The ARISTOTLE trial showed a risk reduction of stroke/systemic embolism (SE) and major bleeding in non-valvular atrial fibrillation (NVAF) patients... 
Coagulation and Fibrinolysis | EFFICACY | RIVAROXABAN | GUIDELINES | RISK | stroke | non-valvular atrial fibrillation | warfarin | DABIGATRAN | THERAPY | major bleeding | Apixaban | DISEASE | PERIPHERAL VASCULAR DISEASE | COMPLICATIONS | OUTCOMES | HEMATOLOGY
Journal Article
Europace, ISSN 1099-5129, 10/2016, Volume 18, Issue 10, pp. 1593 - 1598
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2011, Volume 9, Issue 11, pp. 2168 - 2175
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 08/2019, Volume 288, pp. 72 - 75
Journal Article
Journal Article
Journal Article